{
    "2019-09-11": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS)",
                "features": {
                    "keywords": [
                        "investigation",
                        "Novartis",
                        "AG",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Leaner Pfizer Positioned to Boost R&D Output",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "R&D",
                        "Boost"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Pharma Stock Calls Could Double Fast",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Calls",
                        "Double"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "INVESTOR ALERT: Law Offices of Howard G. Smith Continues its Investigation on Behalf of Novartis AG Investors (NVS)",
                "features": {
                    "keywords": [
                        "investigation",
                        "Novartis",
                        "AG",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Why Amgen Stock Perked Up Last Month",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Stock",
                        "Perked",
                        "Up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-18",
                "original_text": "4 Big Drugmakers Boasting Impressive Oncology Pipelines",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "Oncology",
                        "Pipelines"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-25",
                "original_text": "ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "investigation",
                        "Novartis",
                        "Claims",
                        "Losses"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Allergan's Filings for Abicipar Pegol Accepted in U.S/Europe",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Filings",
                        "Abicipar",
                        "Pegol",
                        "Accepted"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}